Rentokil Initial (RTO) EBT (2021 - 2025)

Rentokil Initial (RTO) posted quarterly EBT of $318.0 million for Q4 2025, up 320.83% quarter-over-quarter from -$144.0 million in Q3 2025.

Rentokil Initial (RTO) EBT (2021 - 2025) Analysis & Trends

Rentokil Initial (RTO) has reported EBT for 4 consecutive years, with $318.0 million the latest figure, recorded in Q4 2025.

In Q4 2025, EBT changed N/A year-over-year to $318.0 million; the TTM figure through Dec 2025 stood at $988.3 million (changed N/A YoY), while the FY2025 annual figure was $390.0 million, down 15.58% from the prior year.
EBT climbed to $318.0 million in Q4 2025 per RTO's latest filing, from -$144.0 million in the prior quarter.
Across five years, EBT topped out at $645.7 million in Q4 2021 and bottomed at -$144.0 million in Q3 2025.
Historically, EBT has averaged $326.8 million across 4 years, with a median of $318.0 million in 2025.
Annual changes were most pronounced in 2022 — EBT tumbled 70.57% — and 2023, when it surged 228.55%.
Rentokil Initial's EBT stood at $645.7 million in 2021, then sank by 70.57% to $190.0 million in 2022, then soared by 228.55% to $624.3 million in 2023, then sank by 49.06% to $318.0 million in 2025.
Business Quant data shows RTO's EBT at $318.0 million in Q4 2025, -$144.0 million in Q3 2025, and $624.3 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT (Qtr)
1	Cintas	81.69 Bn	81.40 Bn	1.48 Bn	648.43 Mn
2	Relx	64.97 Bn	64.80 Bn	-	-
3	Copart	32.09 Bn	28.74 Bn	732.88 Mn	502.09 Mn
4	Global Payments	24.80 Bn	19.40 Bn	2.03 Bn	104.28 Mn
5	Rb Global	16.24 Bn	15.72 Bn	935.50 Mn	186.00 Mn
6	Aramark	15.68 Bn	15.18 Bn	430.34 Mn	135.73 Mn
7	UL Solutions	15.20 Bn	14.77 Bn	417.00 Mn	338.00 Mn
8	Rentokil Initial	11.80 Bn	9.27 Bn	-	-
9	Dolby Laboratories	6.05 Bn	5.38 Bn	264.68 Mn	43.80 Mn
10	Unifirst	5.23 Bn	5.06 Bn	234.73 Mn	24.44 Mn

Download Data